Top news of the week: 20.06.2022.
Biotech Co. Advances 3 New Clinical Stage Assets Research Report
Ocugen Inc.'s product candidates include a COVID vaccine, a gene therapy for eye disease and an orthopedic cell therapy, noted a ROTH Capital Partners report.
Seattle Children’s Invests $45M in Minority Scientists Tackling Pediatric Disease
Many bright young people never get a chance to fulfill their potential as scientists because they never get on the usual scientific career on-ramps. Many young people who get sick struggle ...
Report: Merck Looks into Possible Buyout of Seagen
Pharmaceutical giant Merck is exploring a possible purchase of biotech company Seagen, according to The Wall Street Journal.
Improving Disparity Begins with Us: Biotech Leaders Drive Diversity, Equity and Inclusion in Healthcare
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services.
International Partnerships in Biotech: How Small Details Can Have a Big Impact
By Deanna Petersen, CBO of AVROBIO, and Ted Tanaka, consultant with Tanaka International LLC, as part of the From The Trenches feature of LifeSciVC Imagine yourself setting out to do ...